DS
TXG icon

David Shaw’s 10x Genomics TXG Stock Holding History

David Shaw’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.94M Buy
233,069
+164,512
+240% +$4.31M ﹤0.01% 1916
2026
Q1 		$1.46M Sell
68,557
-105,911
-61% -$2.12M ﹤0.01% 3158
2025
Q4 		$2.85M Buy
174,468
+11,560
+7% +$175K ﹤0.01% 2763
2025
Q3 		$1.9M Sell
162,908
-583,358
-78% -$7.61M ﹤0.01% 3015
2025
Q2 		$8.64M Sell
746,266
-1,235,997
-62% -$11.3M 0.01% 1604
2025
Q1 		$17.3M Buy
1,982,263
+763,665
+63% +$9.63M 0.02% 1036
2024
Q4 		$17.5M Buy
+1,218,598
New +$19.2M 0.01% 1111
2024
Q2 		– Sell
-64,799
Closed -$2.43M – 4858
2024
Q1 		$2.43M Buy
64,799
+59,855
+1,211% +$2.63M ﹤0.01% 2477
2023
Q4 		$277K Sell
4,944
-55,361
-92% -$2.41M ﹤0.01% 3770
2023
Q3 		$2.49M Sell
60,305
-47,225
-44% -$2.46M ﹤0.01% 2399
2023
Q2 		$6M Buy
107,530
+97,299
+951% +$5.27M 0.01% 1725
2023
Q1 		$571K Sell
10,231
-184,026
-95% -$8.59M ﹤0.01% 3494
2022
Q4 		$7.08M Buy
+194,257
New +$6.35M 0.01% 1767
2021
Q4 		– Sell
-3,402
Closed -$495K – 5726
2021
Q3 		$495K Sell
3,402
-32,334
-90% -$5.55M ﹤0.01% 4088
2021
Q2 		$7M Sell
35,736
-55,177
-61% -$9.99M 0.01% 1774
2021
Q1 		$16.5M Sell
90,913
-115,104
-56% -$19.9M 0.02% 1041
2020
Q4 		$29.2M Buy
206,017
+63,898
+45% +$9.27M 0.03% 760
2020
Q3 		$17.7M Buy
+142,119
New +$14.9M 0.02% 899
2020
Q2 		– Sell
-10,973
Closed -$684K – 4264
2020
Q1 		$684K Buy
10,973
+6,970
+174% +$544K ﹤0.01% 3020
2019
Q4 		$305K Buy
+4,003
New +$241K ﹤0.01% 3620

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

David Shaw's TXG Position: Q2 2026 in Review

David Shaw increased its 10x Genomics (TXG) stake by 240% in Q2 2026, buying an estimated $4.31M and bringing the position to 233,069 shares worth $8.94M. The position accounts for ﹤0.01% of the portfolio, ranked #1916.

David Shaw first reported a position in TXG in Q4 2019 and has held it in 20 quarters since. The position peaked at $29.2M in Q4 2020. 389 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • David Shaw held 233,069 shares of 10x Genomics worth $8.94M as of Q2 2026.
  • David Shaw bought 164,512 10x Genomics shares in Q2 2026, an estimated $4.31M.
  • 10x Genomics made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #1916 holding.
  • David Shaw first reported a position in 10x Genomics in Q4 2019 and has held it in 20 quarters since.
  • David Shaw's 10x Genomics position peaked at $29.2M in Q4 2020.
  • 389 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.